NCT00877877 - Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects. | Biotech Hunter

Enrollment

632

Participants

Timeline

Start Date

May 7, 2009

Primary Completion Date

January 6, 2015

Study Completion Date

January 6, 2015

Conditions

Infections, PapillomavirusPapillomavirus Vaccines

Interventions

PROCEDURE

Blood sampling

Blood samples were to be collected at Months 60, 72, 84, 96, 108 and 120

Trial Locations (26)

333

GSK Investigational Site, Taoyuan District

10002

GSK Investigational Site, Taipei

10315

GSK Investigational Site, Berlin

10967

GSK Investigational Site, Berlin

11101

GSK Investigational Site, Tegucigalpa

18109

GSK Investigational Site, Rostock

18246

GSK Investigational Site, Bützow

22307

GSK Investigational Site, Hamburg

24937

GSK Investigational Site, Flensburg

24955

GSK Investigational Site, Harrislee

25899

GSK Investigational Site, Niebüll

38302

GSK Investigational Site, Wolfenbüttel

44866

GSK Investigational Site, Bochum

47877

GSK Investigational Site, Willich

54290

GSK Investigational Site, Trier

68161

GSK Investigational Site, Mannheim

73326

GSK Investigational Site, Deggingen

77694

GSK Investigational Site, Kehl

77955

GSK Investigational Site, Ettenheim

82362

GSK Investigational Site, Weilheim

97070

GSK Investigational Site, Würzburg

97941

GSK Investigational Site, Tauberbischofsheim

99423

GSK Investigational Site, Weimar

Unknown

GSK Investigational Site, Bogotá

GSK Investigational Site, Arraijan/Vista Alegre

GSK Investigational Site, La Chorrera